Stemcell United Ltd. (USZ1) Stock Price & Analysis
USZ1 Stock Chart & Stats
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- EUR 2.07M
- Enterprise Value
- EUR 3.81M
- Total Cash (Recent Filing)
- EUR 259.88K
- Total Debt (Recent Filing)
- EUR 555.74K
- Price to Earnings (P/E)
- ―
- Beta
- 0.23
- Next Earnings
- Mar 04, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Rebound
The sharp revenue rebound indicates improved commercial traction and a stronger level of customer activity than in the prior year. If maintained, a larger revenue base could provide operating leverage and create a foundation for future margin improvement, although profitability is not yet established.
Strong Reported Revenue Growth
The reported revenue growth rate shows substantial expansion from a very low prior-year base, demonstrating that the business has recently increased its commercial scale. Continued conversion of that growth into recurring sales would strengthen the company’s ability to support investment and improve financial resilience.
Expanding Asset Base
Growth in total assets suggests the company has expanded its resource base alongside the revenue rebound. A larger asset platform may support additional commercial activity over the coming periods, provided management can use those resources efficiently and improve returns without adding disproportionate financial strain.
Bears Say
Negative Gross Profit
Negative gross profit means the company is not yet covering the direct costs associated with its revenue, leaving little foundation for sustainable operating earnings. Unless product economics improve materially, further revenue growth may continue to generate losses rather than strengthen cash generation.
Persistent Operating Losses
Persistent operating losses and a net margin near negative 52% indicate that the current business model has not demonstrated sustainable profitability. Ongoing losses can consume resources, restrict internal funding for growth, and make the company more vulnerable if revenue momentum moderates.
Negative Equity And Cash Burn
Negative equity combined with continued operating and free-cash-flow deficits signals substantial financial strain and limited self-funded capacity. The business appears reliant on external funding to continue operations, raising recapitalization risk and reducing flexibility to invest through a prolonged period of losses.
USZ1 FAQ
What is Stemcell United Ltd.’s market cap?
When is Stemcell United Ltd.’s upcoming earnings report date?
Is Stemcell United Ltd. overvalued?
Does Stemcell United Ltd. pay dividends?
What is Stemcell United Ltd.’s EPS estimate?
How many shares outstanding does Stemcell United Ltd. have?
Which hedge fund is a major shareholder of Stemcell United Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Stemcell United Ltd. Stock Smart Score
Company Description
Stemcell United Ltd.
BPH Global Ltd, along with its associated entities, specializes in the procurement, production, promotion, and sale of traditional medicinal items. Its operational reach spans Australia, Singapore, China, and the broader Southeast Asian market. The company's diverse product range features both unprocessed and refined bird's nest offerings, alongside marine botanicals like Caulerpa Lentillifera (sea grapes) and various seaweeds. These products are utilized across multiple industries, including food, nutrition, healthcare, dietary supplements, cosmetics, and personal care. Headquartered in Melbourne, Australia, the company was founded in 1984 and transitioned to its current name, BPH Global Ltd, in June 2023, having previously been known as Stemcell United Limited.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Matthew Robert Leonard
- Employees
- 31
- Website
- bphglobal.com
- Address
- 365 Little Collins Street, Melbourne, VIC, 3000, AU
